Looking Into TransCode Therapeutics's Recent Short Interest - TransCode Therapeutics (NASDAQ:RNAZ)
Source: benzinga.com
Page 3 - Transcode Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Transcode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Transcode Therapeutics Today - Breaking & Trending Today
Reviewing Verve Therapeutics (NASDAQ:VERV) and TransCode Therapeutics (NASDAQ:RNAZ)
Verve Therapeutics (NASDAQ:VERV – Get Free Report) and TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Verve […]
Source: wkrb13.com
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Adagene (NASDAQ:ADAG), Absci (NASDAQ:ABSI)
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
Source: benzinga.com
TransCode Therapeutics, Inc. Announces CEO Changes
TransCode Therapeutics, Inc.?s co-founder and Chief Executive Officer, Michael Dudley, announced his retirement. He will resign as an executive officer of the company effective January 13, 2024....
Source: marketscreener.com
TransCode Reports Additional Restructuring Steps; Chief Executive Michael Dudley to Retire
-- TransCode Therapeutics said late Friday it has taken additional steps in a previously announced restructuring to cut expenses and allow a greater concentration of resources on a planned phase 1...
Source: marketscreener.com